Bupropion confers modest reductions in cancer-related fatigue; benefit stronger for women

CHICAGO — Bupropion conferred modest reductions in cancer-related fatigue compared with placebo, according to results of a randomized phase 3 trial.The benefit appeared particularly strong among women, data presented at ASCO Annual Meeting showed.

Raccontata dahealio.com